CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 89 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $736,000 | +1.8% | 71,478 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $723,000 | -0.3% | 71,478 | +10.8% | 0.00% | 0.0% |
| Q2 2016 | $725,000 | -5.1% | 64,532 | +15.4% | 0.00% | 0.0% |
| Q1 2016 | $764,000 | -26.5% | 55,931 | +2.0% | 0.00% | 0.0% |
| Q4 2015 | $1,040,000 | +1.9% | 54,822 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,021,000 | +26.2% | 54,379 | +0.1% | 0.00% | 0.0% |
| Q2 2015 | $809,000 | +3945.0% | 54,338 | +3949.0% | 0.00% | – |
| Q1 2015 | $20,000 | +33.3% | 1,342 | +21.3% | 0.00% | – |
| Q4 2014 | $15,000 | +7.1% | 1,106 | 0.0% | 0.00% | – |
| Q3 2014 | $14,000 | +27.3% | 1,106 | +3.8% | 0.00% | – |
| Q2 2014 | $11,000 | -95.2% | 1,066 | -93.7% | 0.00% | – |
| Q1 2014 | $229,000 | – | 17,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |